Global Valsartan Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Valsartan Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Valsartan report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Valsartan market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hypertension and Heart Failure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Valsartan industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Valsartan key manufacturers include Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. Novartis, Sun Pharmaceutical, Teva are top 3 players and held % sales share in total in 2022.
Valsartan can be divided into 40 mg Tablets, 80 mg Tablets, 160 mg Tablets and 320 mg Tablets, etc. 40 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Valsartan is widely used in various fields, such as Hypertension, Heart Failure and Heart Attack,, etc. Hypertension provides greatest supports to the Valsartan industry development. In 2022, global % sales of Valsartan went into Hypertension filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Valsartan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Hypertension
Heart Failure
Heart Attack
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Valsartan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Valsartan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Valsartan industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Valsartan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Valsartan introduction, etc. Valsartan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Valsartan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Valsartan industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Valsartan key manufacturers include Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. Novartis, Sun Pharmaceutical, Teva are top 3 players and held % sales share in total in 2022.
Valsartan can be divided into 40 mg Tablets, 80 mg Tablets, 160 mg Tablets and 320 mg Tablets, etc. 40 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Valsartan is widely used in various fields, such as Hypertension, Heart Failure and Heart Attack,, etc. Hypertension provides greatest supports to the Valsartan industry development. In 2022, global % sales of Valsartan went into Hypertension filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Valsartan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application
Hypertension
Heart Failure
Heart Attack
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Valsartan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Valsartan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Valsartan industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Valsartan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Valsartan introduction, etc. Valsartan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Valsartan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.